US FDA Integrated Assessment Roll-Out Expanding By End Of 2021

All NMEs and original BLAs are expected to adhere to the team-based review approach by the end of the year, with expansion to other application types later.

Stacks of paper
The integrated review is intended to streamline FDA product approval packages, which can number in the hundreds of pages. • Source: Alamy

More from Product Reviews

More from Pink Sheet